Insider · CIK 0001678223

Abdollahian Neil

Reports to the SEC for 2 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001678223

Forms 4 and 5

Insider transactions

38 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-08-19	BOLDBoundless Bio, Inc. · Stock OptionD Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−19.9K sh	—	—	0
2024-08-19	BOLDBoundless Bio, Inc. · Stock OptionD Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−82.1K sh	—	—	0
2024-08-19	BOLDBoundless Bio, Inc. · Stock OptionA Award	Chief Business Officer	AAward	+23.2K sh	—	—	23,191
2024-08-19	BOLDBoundless Bio, Inc. · Stock OptionA Award	Chief Business Officer	AAward	+36.9K sh	—	—	36,852
2024-08-19	BOLDBoundless Bio, Inc. · Stock OptionA Award	Chief Business Officer	AAward	+54.9K sh	—	—	54,871
2024-08-19	BOLDBoundless Bio, Inc. · Stock OptionA Award	Chief Business Officer	AAward	+19.9K sh	—	—	19,948
2024-08-19	BOLDBoundless Bio, Inc. · Stock OptionA Award	Chief Business Officer	AAward	+82.1K sh	—	—	82,051
2024-08-19	BOLDBoundless Bio, Inc. · Stock OptionD Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−23.2K sh	—	—	0
2024-08-19	BOLDBoundless Bio, Inc. · Stock OptionD Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−36.9K sh	—	—	0
2024-08-19	BOLDBoundless Bio, Inc. · Stock OptionD Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−54.9K sh	—	—	0
2024-03-27	BOLDBoundless Bio, Inc. · Stock OptionA Award	Chief Business Officer	AAward	+23.2K sh	—	—	23,191
2021-04-01	CDTXCidara Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−1,469 sh	$2.66	−$3,907.54	57,471
2021-03-31	CDTXCidara Therapeutics, Inc.A Award	Chief Business Officer	AAward	+3,500 sh	—	—	58,940
2021-03-17	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Business Officer	AAward	+150K sh	—	—	150,000
2021-01-05	CDTXCidara Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−2,868 sh	$2.06	−$5,908.08	55,440
2020-03-19	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Business Officer	AAward	+115K sh	—	—	115,000
2020-01-03	CDTXCidara Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−940 sh	$3.42	−$3,214.8	50,308
2020-01-03	CDTXCidara Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−2,340 sh	$3.42	−$8,002.8	51,248
2019-12-18	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Business Officer	AAward	+9,721 sh	—	—	9,721
2019-12-18	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Business Officer	AAward	+56.9K sh	—	—	56,945
2019-12-18	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−100K sh	—	—	0
2019-12-18	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Business Officer	AAward	+29.6K sh	—	—	29,629
2019-12-18	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Business Officer	AAward	+3,704 sh	—	—	3,704
2019-12-18	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Chief Business Officer	DDisposition to Issuer	−50K sh	—	—	0
2019-10-01	CDTXCidara Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−7,284 sh	$1.98	−$14.4K	49,588
2019-09-12	CDTXCidara Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−4,900 sh	—	—	9,100
2019-09-12	CDTXCidara Therapeutics, Inc.A Award	Chief Business Officer	AAward	+17.5K sh	—	—	51,972
2019-09-12	CDTXCidara Therapeutics, Inc.A Award	Chief Business Officer	AAward	+4,900 sh	—	—	56,872
2019-09-12	CDTXCidara Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Business Officer	MExercise/Conversion	−17.5K sh	—	—	7,500
2019-03-21	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Business Officer	AAward	+77K sh	—	—	77,000
2019-03-08	CDTXCidara Therapeutics, Inc.S Sale	Chief Business Officer	SSale	−2,300 sh	$2.44	−$5,612	30,472
2019-01-31	CDTXCidara Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+14K sh	—	—	14,000
2019-01-31	CDTXCidara Therapeutics, Inc.A Award	Chief Business Officer	AAward	+6,000 sh	—	—	32,772
2018-03-29	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Business Officer	AAward	+70K sh	—	—	70,000
2017-09-18	CDTXCidara Therapeutics, Inc. · Restricted Stock UnitM Exercise/Conversion	Chief Business Officer	MExercise/Conversion	+25K sh	—	—	25,000
2017-09-18	CDTXCidara Therapeutics, Inc.A Award	Chief Business Officer	AAward	+15K sh	—	—	20,421
2017-03-31	CDTXCidara Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Business Officer	AAward	+50K sh	—	—	50,000
2016-07-01	CDTXCidara Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Business Officer	AAward	+100K sh	—	—	100,000

Recent filings

Accepted (ET)
Aug 204
Abdollahian Neil0000950170-24-099303
SEC(opens sec.gov)
Mar 294
Abdollahian Neil0000950170-24-038695
SEC(opens sec.gov)
Apr 54
Abdollahian Neil0001610618-21-000032
SEC(opens sec.gov)
Mar 194
Abdollahian Neil0001610618-21-000022
SEC(opens sec.gov)
Jun 254/A
Abdollahian Neil0001209191-20-039025
SEC(opens sec.gov)
Mar 234
Abdollahian Neil0001209191-20-020756
SEC(opens sec.gov)
Jan 64
Abdollahian Neil0001209191-20-002034
SEC(opens sec.gov)
Dec 204
Abdollahian Neil0001209191-19-061574
SEC(opens sec.gov)

Companies

Address

6310 NANCY RIDGE DR SUITE 101

SAN DIEGO, CA, 92121